This weekly video program highlights the latest in pharmacy news, product news, and more.
Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses different legislative issues generating buzz on the state level, including biosimilars.
Pharmacists should take some time to counsel patients on the pros and cons of each antidepressant to help them select the best regimen.
Roche has launched a new HbA1C test to identify diabetes risk and diagnose and monitor patients with diabetes.
Taking hypertension medications at bedtime can improve blood pressure control and reduce the risk of developing diabetes.
Patients with heart failure (HF) are predisposed to falls for a variety of reasons.
The FDA has approved Alkermes’ extended-release aripiprazole lauroxil injection (Aristada) for the treatment of schizophrenia in adults.
The FDA has accepted Sandoz’s Biologics License Application (BLA) for its proposed etanercept (Enbrel) biosimilar.
While flu vaccine effectiveness is traditionally measured across medically attended influenza patients, health care professionals can benefit from learning how the vaccine works in patients who don’t seek treatment.
Pharmacists can lead by example by promoting the FDA’s patient safety initiatives in their practice settings.
The historic Trans-Pacific Partnership negotiations finalized today could affect the cost of health care in significant ways.
Approximately 65% of individuals undergoing chemotherapy will experience chemotherapy-induced hair loss, which is usually temporary and completely reversible when therapy ends.
If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Peptic ulcer disease leads to 1 million hospitalizations and 6500 deaths annually.
Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.
Strategic Alliance Partners